Latest Amphetamines Stories
ZUG, Switzerland, May 26, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that new data advancing the understanding of attention deficit/hyperactivity
The First, Once-Daily, Extended-Release Amphetamine-based Oral Liquid for the Treatment of ADHD MONMOUTH JUNCTION, N.J., May 21, 2015 /PRNewswire/ -- Tris Pharma, Inc.
NEW HAVEN, Conn., May 13, 2015 /PRNewswire/ -- LCS Group, LLC announced today its exclusive license from Lucerne Biosciences, LLC to commercialize U.S. Patent No. 8,318,813 and U.S.
LEXINGTON, Massachusetts, May 11, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that new research highlighting its commitment to the treatment
Harbor Village Detox comments on The New York Times’ recent article regarding the abuse of the prescription medication adderall to increase work performance among the business class.
LEXINGTON, Massachusetts, April 7, 2015 /PRNewswire/ -- - Potential Launch of SHP465 Anticipated in Second Half of 2017 - Exclusivity for Shire's
OTTAWA, March 30, 2015 /CNW/ - Stronger, clearer warnings on the risk of suicidal thoughts and behaviours are being incorporated into the prescribing information for drugs used in the management
LEXINGTON, Massachusetts and CINCINNATI, March 26, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) and Cincinnati Children's Hospital Medical Center today announced
WILMINGTON, Del., March 6, 2015 /PRNewswire/ -- Lucerne Biosciences, LLC announced today the U.S. Patent and Trademark Office's publication of U.S. Patent Application No.
LEXINGTON, Massachusetts, March 2, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the company has submitted a New Drug Application (NDA) with
- A young chicken: also used as a pet name for children.